Hot Products

Syringetin-3-O-glucoside
Catalog No: CFN90468

Reference standards.
Syringetin-3-O-rutinoside
Catalog No: CFN91150

Reference standards.
Syringic acid
Catalog No: CFN98884

Syringic acid is a potential antioxidant used in traditional Chinese medicine and is an emerging nutraceutical. It has potential anti-angiogenic, anti-glycating, anti-hyperglycaemic,antimicrobial, fungitoxicity, neuroprotective, antimitogenic, chemo-sensitizing, anti-obesity, anti-inflammatory, anti-steatotic, and memory-enhancing properties. Syringic acid can ameliorate L-arginine methyl ester-induced hypertension by reducing oxidative stress, and can reduce the pancreatic damage induced by alloxan and stimulated β-cell regeneration in diabetic rats. Syringic acid can suppress hepatic fibrosis in chronic liver injury, it inhibits the activation of cultured hepatic stellate cells.
Syringin
Catalog No: CFN99282

Syringin (Eleutheroside B) has neuroprotective, tonic, adaptogenic, antitumour, anti- platelet aggregation, anti-inflammatory, antinociceptive ,and immune-modulating properties. It reduced the expression levels of inducible NO synthase (iNOS) ,COX,TNF-α, Beta Amyloid, and Caspase.
Syringol
Catalog No: CFN92626

Syringol and phenol have modifying effect on NMOR formation in vivo to be similar, the effect of food on NMOR levels in blood is more important than that of the modifiers.
Syringylpropane
Catalog No: CFN92632

Standard reference
Syzalterin
Catalog No: CFN96061

Syzalterin can protect PC12 cells effectively against Abeta-induced toxicity.
Tabersonine
Catalog No: CFN98678

Tabersonine is a precursor for vincristine used in cancer chemotherapy, the biocompatibility and small size essential for permeating the blood-brain barrier make it a potential therapeutic drug candidate for treating AD.
Taccalonolide A
Catalog No: CFN90596

Taccalonolide A is the first microtubule stabilizing agent to be discovered from a plant since identification of the mechanism of action of paclitaxel and it is the first natural product steroid identified to have these cellular effects.
Taccalonolide AJ
Catalog No: CFN90935

Taccalonolide AJ is a microtubule stabilizer; it has excellent and highly persistent antitumor efficacy when administered directly to the tumor, suggesting that the lack of antitumor efficacy seen with systemic administration of AJ is likely due to its short half-life in vivo.